CM
IRON icon

Caption Management’s Disc Medicine IRON Stock Holding History

Caption Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69,800
Closed -$4.35M – 1333
2024
Q1 		$4.35M Sell
69,800
-92,500
-57% -$6M 0.07% 325
2023
Q4 		$9.37M Buy
162,300
+135,600
+508% +$6.94M 0.13% 194
2023
Q3 		$1.25M Buy
+26,700
New +$1.34M 0.02% 708
2021
Q3 		– Sell
-2,893
Closed -$561K – 1642
2021
Q2 		$561K Buy
2,893
+33
+1% +$10.8K 0.01% 1016
2021
Q1 		$1.16M Buy
+2,860
New +$1.28M 0.03% 650

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Caption Management's IRON Position: Q1 2024 in Review

Caption Management sold out of Disc Medicine (IRON) in Q1 2024, closing a stake of 43,000 shares — an estimated $2.79M sold.

Caption Management first reported a position in IRON in Q2 2021 and held it in 2 quarters. The position peaked at $2.48M in Q4 2023. 130 funds tracked by Wall St. Rank hold IRON as of Q1 2024.

  • Caption Management reported no remaining Disc Medicine position as of Q1 2024 after selling out during the quarter.
  • Caption Management sold 43,000 Disc Medicine shares in Q1 2024, an estimated $2.79M.
  • Caption Management first reported a position in Disc Medicine in Q2 2021 and held it in 2 quarters.
  • Caption Management's Disc Medicine position peaked at $2.48M in Q4 2023.
  • 130 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2024.

Based on Caption Management's 13F filing for Q1 2024, filed 15 May 2024.